Purpose: Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a radiological tool for the detection and discrimination of breast lesions. The aim of this study is to evaluate a computer-aided diagnosis (CAD) system for discriminating malignant from benign breast lesions at DCE-MRI by the combined use of morphological, kinetic, and spatiotemporal lesion features. Methods: Fifty-four malignant and 19 benign breast lesions in 51 patients were retrospectively evaluated. Images were acquired at two centers at 1.5 T. Mass-like lesions were automatically segmented after image normalization and elastic coregistration of contrast-enhanced frames. For each lesion, a set of 28 3D features were extracted: ten morphological (related to shape, margins, and internal enhancement distribution); nine kinetic (computed from signal-to-time curves); and nine spatiotemporal (related to the variation of the signal between adjacent frames). A support vector machine (SVM) was trained with feature subsets selected by a genetic search. Best subsets were composed of the most frequent features selected by majority rule. The performance was measured by receiver operator characteristics analysis with a stratified tenfold cross-validation and bootstrap method for confidence intervals. Results: SVM training by the three separated classes of features resulted in an area under the curve (AUC) of 0.90 6 0.04 (mean 6 standard deviation), 0.87 6 0.06, and 0.86 6 0.06 for morphological, kinetic, and spatiotemporal feature, respectively. Combined training with all 28 features resulted in AUC of 0.96 6 0.02 obtained with a selected feature subset composed by two morphological, one kinetic, and two spatiotemporal features. Conclusions: Quantitative combination of morphological, kinetic, and spatiotemporal features is feasible and provides a higher discriminating power than using the three different classes of features separately.
I. INTRODUCTION
Breast cancer is one of the leading causes of death in women. 1, 2 Scientific evidence indicates that early detection and treatment of breast cancer can reduce the mortality and morbidity. 3, 4 Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has evolved into an established clinical imaging modality for detection and diagnosis of breast lesions. The American Cancer Society has issued a guideline recommending annual breast MRI as an adjunct to mammography for screening women with lifetime breast cancer risk greater than 20%-25%, 5 an indication confirmed by recent studies. 6, 7 Moreover, indications for breast MRI now include not only screening high-risk women but also presurgical staging, therapy response monitoring, and searching for occult primary breast cancer, as recently discussed by a multidisciplinary group. 8 Breast MRI currently demonstrates a high sensitivity (ranging 93%-100%) and a more variable specificity.
9-13 A robust estimate for specificity has been produced by a large meta-analysis by Peters et al.
14 who reported a value of 72% (combine with a sensitivity of 92%). Moreover, the diagnostic performance is subjected to the level of experience of the radiologist. [16] [17] [18] In an attempt to address this issue, the BI-RADS (breast imaging reporting and data system) MRI lexicon 19 was developed to provide standardized criteria and descriptors for reporting breast MRI findings. In particular, the BI-RADS lexicon provides terminology for describing enhancement kinetic behavior and morphology of a lesion. Computer-aided detection (CADe) and diagnosis systems (CADx) could provide an accurate and time efficient support to the interpretation of breast MR images by improving lesion detection and differentiation between malignant and benign nodules. 15 Research has been undertaken on developing computeraided systems for DCE-MRI for detection and diagnosis of breast tumors. Typically, CAD systems characterize morphological and contrast enhancement kinetics features of lesions, in order to depict differences between malignant and benign lesions. [20] [21] [22] [23] [24] [25] [26] [27] Indeed, spatial attributes such as spiculated margins and irregular shapes are important predictors of malignancy, whereas smooth border and round shapes are more often associated with benignancy; 28 heterogeneous and peripheral internal enhancement is an important indicator of malignancy, whereas homogenous enhancement is often associated with benignancy. 28, 30 Temporal attributes such as early strong enhancement with rapid wash out are more frequently found in malignant lesions, whereas benign lesions have typically slow persistent enhancement increase. 28, 31 Recent reports have introduced another class of features related to the spatial variations of temporal signal enhancements at a pixel scale to capture the complexity of the spatiotemporal association of tumor enhancement patterns, proving differentiation of malignant and benign lesions. [32] [33] [34] [35] The concept of studying spatiotemporal properties is related to the lesion internal enhancement, but it is extended to capture a measure of the complex change in this feature as a function of contrast enhancement with more rigorous mathematical frameworks. In most of previous studies, however, the combination of all three classes of morphological, kinetic, and spatiotemporal features was rarely investigated. Moreover, most of proposed CAD schemes are not automatic, since they are based on either manual lesion detection or manual lesion segmentation.
The aim of this study is to present a full scheme for the discrimination of malignant from benign breast lesions detected and segmented automatically. Discrimination is based on quantitative extraction of features, diagnostic feature selection, and lesion classification. In particular, quantitative feature extraction includes the calculation of a pool of three classes of features: morphological, contrast enhancement kinetic, and spatiotemporal features. New morphological and contrast enhancement kinetic features are introduced together with those already reported in the literature. Spatiotemporal properties are analyzed with features extracted from new dedicated maps. Genetic algorithms (GAs) are used to choose the most performing feature subset from the feature pool. The optimal feature subset is used to train a classifier based on support vector machines (SVMs) classifying lesions into malignant or benign.
II. MATERIALS AND METHODS

II.A. MRI protocols
Breast MRI studies were acquired at two centers. The first group contains 26 studies acquired with a 1.5-T scanner (Sigma Exite Hdx, General Electric Healthcare, Milwakee, USA) using an eight-channel breast RF coil and a fatsaturated three dimensional (3D) axial fast spoiled gradientecho sequence [VIBRANT(TM), general electric] with the following technical parameters: TR/TE ¼ 4.5/2.2 ms, flip angle ¼ 15 , reconstructed matrix 512 Â 512, field of view 32 cm, slice thickness 2.6 mm, and pixel size 0.39 mm 2 . The 3D sequence was acquired once before and 5 times after intravenous injection with time resolution 50 or 90 s; a late acquisition frame was obtained 7 min after contrast injection. Gadopentetate dimeglumine (Gd-DPTA, Magnevist, BayerSchering, Berlin, Germany) was administered at a dose of 0.1 mmol/kg at 2 ml/s, followed by 20 ml of saline solution at the same rate. The second group comprised 25 studies performed on a different 1.5-T scanner (Sonata Maestro Class, Siemens, Erlangen, Germany), using a standard bilateral breast coil (four-element; two-channel) and a dynamic 3D axial fast low angle shot sequence with the following technical parameters: TR/TE ¼ 11/4.9 ms, flip angle 25 , reconstructed matrix 512 Â 512, field of view 38 cm, slice thickness 1.3 mm, and pixel size 0.56 mm . Gadobenate dimeglumine (MultiHance, Bracco, Milan, Italy) was used as contrast material, administered at a dose of 0.1 mmol/kg at 2 ml/s, followed by 20 ml of saline solution at the same rate. One baseline scan was acquired prior to contrast injection, followed by five postcontrast frames taken 118 s apart.
The Local Ethical Committees approved the retrospective use of the database for scientific purposes and waived from informed consent. The study was conducted in accordance with national legislation and the declaration of Helsinki.
II.B. Lesion dataset
Overall, the dataset contained 73 mass-like lesions collected from small consecutive series and confirmed by histopathology (core-biopsy and/or surgical specimen): 54 malignant and 19 benign lesions (Table I ). Figure 1 shows examples of malignant and benign lesions.
Lesion size was 13 6 8.4 mm (mean 6 standard deviation) for benign lesions and 16.1 6 14.7 mm) for malignant lesions, with lesion size determined as the longest diameter measured by radiologists. Thirty three lesions had a size smaller than 10 mm (22 malignant, 11 benign), whereas 40 lesions had a size larger than 10 mm (32 malignant, 8 benign). Table I summarizes lesions histology.
II.C. Lesion detection and segmentation
Automatic lesion detection and segmentation were carried out as already described in detail in Refs. 36 and 37 . To summarize the method, unenhanced and contrast-enhanced frames are aligned with an elastic coregistration algorithm, in order to correct for possible misalignments in the dynamic sequence; then, subtracted images (contrast-enhanced minus unenhanced) are calculated. Exploiting a priori knowledge, the breast area is segmented to discard enhanced anatomical structures located outside the region of interest (e.g., heart). After breast segmentation, images are normalized to the contrast enhancement of mammary vessels, in order to correct for variations of acquisition parameters and contrast material. Mammary vessels are segmented with a method proposed by Sato et al. 38 Finally, a histogram based threshold is applied to select enhanced areas, and filters based on morphology and kinetic characteristics are applied, to reduce the number of false positive findings. Figure 1 shows examples of segmentation masks for a malignant and benign lesion.
The detection and segmentation algorithm generated a number of candidate lesions. The candidates corresponding to true lesions were manually confirmed by expert radiologists and associated to histology. Morphological, enhancement kinetic, and spatiotemporal features were extracted from these confirmed detections. These features are described in the following sections and summarized in Table II .
II.D. Morphological features
Two morphological features related to the lesion shape are calculated on the binary mask: circularity and convex index. Circularity 20 is defined as lesion volume within sphere of effective diameter lesion volume ;
where the effective diameter is defined by
and coindex is given by volume of convex hull lesion volume ;
with the convex hull computed using the algorithm described in Ref. 39 . Three features are used to describe the margin of a lesion: irregularity, mean, and standard deviation of angles between surface normals 40 (ABSN). 
The ABSN is a measure of tortuosity, computed at every voxel in a surrounding layer around the lesion border, defined as the sum of angles between n i and its neighbors n ij
where the vectors n i are approximated by normalized gradient vectors. The average ABSN will be zero on a regular, flat border as the neighboring normal vectors are nearly parallel, while it will be within (0, p] on an irregular, curved surface. These features, describing lesion margins, are computed on the maximum intensity projection image along time (MIPT), where each pixel takes the maximum value among the corresponding pixels in all time frames. Therefore, in the MIPT all parts of the lesion uptaking contrast along time frames are visible. Other six features characterizing the internal enhancement pattern are extracted: the autocorrelation function (evaluated at 2 mm displacement), two features related to the peripheral uptake, and the mean and standard deviation of the shape index 41 computed inside the segmented mass. The internal enhancement features are computed on the first contrast-enhanced subtracted image in order to analyze the early contrast enhancement pattern. The periphery and the center of some malignant lesions show different enhancement characteristics after injection of contrast material at MRI. 42, 43 In this work, we have developed an algorithm to make a quantitative analysis of the peripheral uptake. First, a flood-fill operation is performed on the original binary mask in order to fill segmentation holes, and the distance transform is applied to the filled binary mask B1 (Fig. 2) to label each lesion voxel with its distance from the lesion nearest border. Then, a new binary image, B2, is created by setting the voxels with intensities greater than the median contrast value inside the lesion to foreground and the remaining voxel to background. The function H(d) is extracted as
where d is the distance from the lesion border normalized by the maximum value of such distance within the lesion. A third-degree polynomial is fitted on H(d) and the second and third order fitting coefficients are used as peripheral uptake quantitative features. Another useful descriptor of the mass is the level of contrast homogeneity within lesion. This properties is described by the local shape index computed for each lesion voxel to characterize the shape of a local isosurface passing through a voxel p. This isosurface can be represented in a parametric 2D form as P ¼ fðu; vÞ 2 R 2 ; hðu; v; /ðu; vÞÞ ¼ ag, and the principal curvatures k 1 and k 2 are obtained as the eigenvalues of the Weingarten endomorphism. Then the shape index (SI) S(p) at the voxel p is defined as 41 
SðpÞ
where k max ¼ maxðk 1 ; k 2 Þ and k min ¼ minðk 1 ; k 2 Þ. Since the SI is related to the curvature of the intensity Mean of angles between surface normals, mean(ABSN) 5 Standard deviation of angles between surface normals, std(ABSN) 6 Autocorrelation, AutoCorr 7
First coefficient of peripheral uptake (peripheralUptake1) 8
Second coefficient of peripheral uptake (peripheralUptake2) 9
Mean of Shape Index, mean(SI) 10
Standard deviation of Shape Index, std(SI) Kinetic 11
Mean of amplitude coefficients A of function (9), mean(A) 12 Standard deviation of amplitude A coefficients of function (9), std(A) 13 Entropy of amplitude coefficients A of function (9), entropy(A) 14 Mean of decay coefficients D of function (9), mean(D) 15 Standard deviation of decay coefficients D of function (9), std(D) 16 Entropy of decay coefficients D of function (9) 
II.E. Enhancement kinetic features
Enhancement kinetics is related to the time course of signal intensity over time. We denote Sðr; iÞ as the voxel value at location r in the lesion at time frame i, where i runs from 0 (precontrast frame) to N (last postcontrast frame). The intensity Sðr; iÞ is normalized to the contrast enhancement of mammary vessels, in order to correct for variations of acquisition parameters and contrast material. For each lesion voxel, the contrast enhancement is computed as Cðr; iÞ ¼ Sðr; iÞ À Sðr; 0Þ Sðr; 0Þ
where the quantity Cðr; iÞ is related to the contrast material concentration in the extracellular space of breast tissue in r. 44 Note that at i ¼ 0, Cðr; iÞ ¼ 0. Two types of features are derived from the enhancement kinetics. The first type is related to the fitting of the contrast enhancement to the following analytical exponential function:
where A controls the function amplitude and therefore the contrast uptake, whereas D captures the function decay and thus the contrast washout. Coefficients A and D were used as features. Figure 4 shows examples of A and D maps for the malignant and the benign lesion shown in Fig. 1 . The malignant lesion has heterogeneous maps, whereas the benign lesion has homogeneous maps. Moreover, the malignant lesion shows a relative large uptake and large washout in the central lesion zone, whereas the benign lesion shows a weaker washout all over the volume. We characterized the lesion contrast uptake and washout by fitting the contrast enhancement Cðr; iÞ with an analytical function rather than using a two-compartmental pharmacokinetic model. 45 The use of a pharmacokinetic model implies strict constrains on temporal resolution of MRI technique to measure contrast material concentration in an artery (arterial input function) and in the tissue (tissue residue function). 46 These constrains are not fulfilled in DCE-MRI acquisition protocols typically used in clinical practice. Although the analytical function proposed [Eq. (9)] cannot model physiologically the lesion, its simple form allows for relaxing constrains on the acquisition protocols still characterizing the kinetic behavior of the lesion. The second type of feature computes the area under the contrast enhancement curve Cðr; iÞ. This feature is related to the total amount of contrast material in the lesion tissue. For each of the three features, mean, standard deviation, and entropy were computed, yielding a total of nine contrast enhancement kinetic features.
II.F. Spatiotemporal features
Spatiotemporal features are related to the spatial variation of contrast enhancement over time. The lesion spatial variation of the contrast is represented as a signal intensity flow. At voxel-scale, the flow can be studied looking at voxel signal intensity changes from frame to frame in relation to neighboring voxels. For example, if a voxel appears brighter than its neighbors in a given frame, and appears darker in the subsequent frame, we may say that the signal intensity is flowing out of the voxel. We denote Dðr; jÞ as the voxel signal intensity difference between adjacent frames at location r, j running from 0 (precontrast) to N À 1, where N is the number of frames. For each Dðr; jÞ, the vector field Gðr; jÞ is computed as Gðr; jÞ ¼ r Á Dðr; jÞ:
(10)
Gðr; jÞ represents the signal intensity change between adjacent frames and quantifies the amount of intensity that has flowed from a voxel to its neighbors. Gðr; jÞ is topologically characterized using the Jacobian matrix Jðr; jÞ
and calculating the three eigenvalues of the characteristic equation
where P ¼ ÀtraceðJÞ and Q ¼ jJj. Each voxel of the vector field Gðr; jÞ is therefore topologically characterized by three eigenvalues k i (i ¼ 1, 2, 3). A voxel represents a source of signal if all three eigenvalues are positive, whereas it is a sink of signal if the eigenvalues are negatives. 47 The voxel topological information is summarized by the calculation of the eigenvalues trace trðrÞ
Sinks and sources are characterized by negative and positive traces, respectively. Mean, standard deviation, and range (max-min) of the N À 1 traces are calculated for each voxel, and three maps are generated: MeanTr(r), StdTr(r), and RangeTr(r). Out of each map, lesion mean, standard deviation, and entropy are computed, to get a total of nine spatiotemporal features. Figure 5 shows examples of MeanTr and StdTr maps for the malignant and the benign lesion shown in Fig. 1 . Values are reported in arbitrary units. The MeanTr map of the malignant lesion shows smaller values at the boundary than in the center, whereas the benign lesion shows an opposite behavior. This can be explained by the fact that the malignant lesion shows over the time a strong washout from the center to the boundary as shown in Fig. 1 . Accordingly, the trace values in the center, immediately after the contrast injection, are lower than those at the boundary, the lesion center behaves as a sink. These trace values at center in the late dynamic series decrease their negative values since the center acts as a source. This results, on average, in less negative trace values at the center than at the boundary. Considering the StdTr maps, the malignant lesion shows a pattern more heterogeneous than that of the benign lesion.
II.G. Feature selection
A feature selection method based on the wrapper approach 48 was used in our study in order to select an optimal subset of the original features. Wrapper approach uses the performance of the learning algorithm as feature evaluation function; therefore, the selected feature subset (FS) is dependent on the chosen classifier. The performance measure is the area under the receiver operator characteristics (ROC) curve (AUC) calculated with a tenfold crossvalidation. Feature selection has been carried out through a genetic approach. Genetic algorithms are search and optimization algorithms based on natural evolution and selection as means of determining an optimal solution to feature selection problem. A cross generational elitist selection, heterogeneous recombination, and cataclysm mutation genetic algorithm 49 is used to search through candidate subsets of features. This GA starts with an initial random population of dimension N, each individual in the population represents a candidate solution to the feature subset selection problem and is represented by a binary string, called chromosome, having a length equal to the total number of features, each bit representing the presence or absence of a feature. The fitness of an individual is determined by the following equation: (14) where the AUC is the area under the ROC curve, k is a constant (k ¼ 1), nMalLesions is the number of malignant lesions used in the training, and nSelectFeat is the number of selected features in a given individual. The fitness is composed of two competing terms. The first term ð1 À AUCÞ is formed by individuals with high classification performances that tend to have a larger number of features. The smaller this part is, the more discriminating the individuals are. The second term acts as a penalty term, discouraging selection of individuals having large number of active features. The weight of the penalty term is controlled by the constant k, with large k values promoting individuals with a small number of features. Each feature subset selection experiment is composed of ten experiments of tenfolds cross-validation. Each crossvalidation generates ten feature subsets, keeping iteratively one of the ten folds out of the GA search and using the remaining nine folds for the selection of an optimal candidate feature subset with a further tenfold cross-validation. Repeating this procedure for the remaining nine folds, ten subsets are selected. After ten experiments of crossvalidation, 100 candidates feature subsets are generated. The optimal feature subset is selected by the majority rule out of the 100 candidate subsets. Cross-validation is carried out keeping constant the proportion between malignant and benign lesions in order to reduce validation bias. Moreover, in the training, the lesions of the minority class (i.e., benign class) are duplicated to balance the number of lesions of the majority class and reduce the classification bias.
II.H. Classification
Support vector regressors -SVRs are used because of their good generalization and ability to solve many practical problems, such as small sample, non linearity, and high dimensionality. 50, 51 SVRs map the input space into the highdimensional feature space and determine the optimal hyperplane given by
where w is the one-dimensional weight vector, gðxÞ is the mapping function that maps the input feature vector x into the one-dimensional space, and b is the bias term. In -SVR, a piecewise error function E(r) is defined as
where the residual r is the difference between the expected response y and the predicted value f ðxÞ. The solution is determined in order to minimize the structural risk, i.e., the probability of testing patterns to be classified correctly for a fixed but unknown probability of the data. The solution of the constrained minimization problem is
where a i and a Hðx i ; xÞ ¼ g T ðx i ÞgðxÞ is the kernel which maps the feature vectors into higher dimensional spaces to achieve better class separation translating nonlinear boundaries in the original space into linear boundaries. For our classification problem, the radial basis kernel proved to yield the best result
where c is the kernel parameter and the support vectors x i are the center of the radial basis functions.
II.I. Experiments and performance evaluation
A series of experiments were carried out to evaluate the performance of the discrimination system using different classes of features. Three experiments were performed using the three classes of features separately; three other experiments used paired classes of features; the last experiment used all features. For all experiments, AUC was calculated to quantitatively estimate the performance. ROC curves are calculated from the feature subsets selected by the genetic search with a tenfold cross-validation strategy. Moreover, performances were reported for each selected feature subset in terms of sensitivity, specificity, positive predictive value, negative predictive value, and accuracy. Performances were calculated at the ROC point with the highest accuracy, the point closest to the top-left corner (0,1) of the ROC.
Finally, classification performances were also evaluated according to the lesion size, grouping lesions based on their size being smaller than 10 mm or larger or equal to 10 mm. Two separate training procedures were carried out using the most discriminating feature subset found in the previous experiments. AUC values and p-value were also calculated.
II.J. Statistical analysis
The bootstrap technique was used in order to estimate the confidence interval of AUC and to compare the classification performances of the different selected features subsets. 53 To obtain the statistics of AUC values, 200 sets of malignant and benign lesions were formed by sampling with replacement from the whole dataset. The ROC and AUC for each set was then calculated with a tenfold cross-validation strategy and the 95% confidence interval for AUC was derived from this collection of measurements. A Wilcoxon matched pairs one-tailed test was also performed to determine the significance level of the performance improvement, evaluating the p-value between each features subsets selected in the experiments with separated and paired classes of features and the feature subset obtained using all classes of features, under the null hypothesis that there exists no AUC value difference between them against the alternative hypothesis that the performance of combined morphologic, kinetic, and spatiotemporal features is better than the performance of the other features subsets. (p-values were considered significant when lower than 0.05). Wilkonox test was chosen as statistical test since the assumption of normality was not valid on the distribution of AUC values. Figure 6 shows the ROC curves related to the feature subsets selected in separated genetic searches for each class of features (morphological, kinetic, and spatiotemporal) and to the features subset selected by the genetic search using all three classes of features. Each figure contains mean ROC curves.
III. RESULTS
The Table III reports the selected feature subsets and the mean and standard deviation of the AUC values calculated with 200 bootstrap replicates, as described above. Table III Table IV shows performances for each selected feature subset in terms of sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy.
The AUC values for the small lesion and the large lesion groups were 0.92 6 0.05 and 0.96 6 0.04, respectively (p < 0.001). Table V reports performances in terms of sensitivity, specificity, positive predictive value, negative predictive value, and accuracy.
IV. DISCUSSION
We developed and analyzed an automatic CADx system to discriminate malignant from benign breast mass-like lesions at DCE-MRI. The system is based on the combination of three groups of features (morphological, kinetic, and spatiotemporal), each of them working on different properties of breast lesions. FSs were selected from each single group and from their combinations. The selected feature subsets were used to evaluate the diagnostic performance in distinguishing between benign and malignant lesions by ROC analysis. The AUC for the FS resulting from the combination of all three feature groups, AUC(FS7), was significantly higher than those obtained with all other selected FSs, showing that the combination of features increases the classification performances.
The morphological feature group resulted the most discriminating (AUC ¼ 0.90), followed by the kinetic (AUC ¼ 0.87) and spatiotemporal feature groups (AUC ¼ 0.86). This result could be considered as a CADx prevalence of morphologic features in comparison with kinetic features and in some way corresponds to clinical practice: a spiculated lesions should be evaluated with needle-biopsy, independently from kinetics. 19 Nevertheless, the combination of the spatial-temporal features with kinetic ones or with morphological and kinetic features resulted in a high classification performances (respectively, AUC ¼ 0.93 and 0.96), suggesting that they provide an independent information to the other two features classes.
From the entire pool of 28 features, 16 features were selected in the 7 classification experiments. Among these 16 features, we focused on 7 features that were chosen more than once in the selected FSs, thus being more significant. This small set of features was composed of four morphological, one kinetic, and two spatiotemporal features. Morphological features are mean of angles between surface normals, mean(ABSN), standard deviation of angles between surface normals, std(ABSN), standard deviation of shape index, std(SI), and peripheral uptake. We can say that these features describe lesion margin and internal enhancement pattern. The selected kinetic feature is the mean of voxels decay rates of the analytical function [Eq. (9)] mean(D). They characterize the lesion contrast washout. These morphological and kinetic features should be considered as the main lesion properties used by radiologists for identifying malignant tumors, in agreement with clinical observations 28 predictive models. 29 The selected spatiotemporal features are the mean of mean eigenvalue-trace image, mean(-MeanTr), and the standard deviation of mean eigenvaluetrace image std (MeanTr). Qualitatively, these features describe whether the signal intensity flows in or out of the voxels, on average over time. The selection of these features is reasonable, since they provide an independent information to that provided by morphological and kinetic features.
Lesions larger or equal to 10 mm were classified significantly better (AUC ¼ 0.96) than those smaller than 10 mm (AUC ¼ 0.92). Notably, morphological features showed a lower ability to discriminate between malignant and benign findings in the case of smaller lesions. This can be due to the low spatial resolution used in the MRI clinical studies.
Patient motion during acquisitions of different MR datasets may introduce inaccuracies in the discrimination of lesion properties. To this end, a nonrigid image coregistration was applied to dynamic series to correct for such motion before lesion segmentation and discrimination. 36 Different contrast materials were used in the two acquisition protocols. This could have determined variations in lesion kinetics and introduced potential misinterpretations in quantitative evaluation of kinetic and morphologic lesion properties. In order to avoid this misleading effect, kinetic curves were normalized by the mean values intensity measured at the mammary arteries, and morphological descriptors were designed to be robust to variations of acquisition parameters and contrast material.
A pool of features produces a feature space to be searched for optimal feature subsets. The larger the number of initial features, the larger is the feature space to be spanned and the larger can be the number of selected feature subsets. In this work, a genetic algorithm was used to select feature subsets, in order to prevent unnecessary computation, overfitting, and to ensure a reliable classifier. The genetic algorithm was driven by the fitness function in order to search for performing feature subsets with a reasonable number of features. Indeed, the selected feature subsets were composed of a limited number of features that ranged from 3 to 5.
The total number of features was limited to 28 to avoid potential overfitting of the small dataset. Moreover, the three groups of features were limited to have a similar number of features to prevent class overweighing and potential unbalanced comparison among feature classes. Indeed, the obtained selected feature subsets were composed of a balanced number of features of the different feature classes, e.g., FS4, FS6, and FS7. Finally, the performances obtained were evaluated with a stratified tenfold cross-validation method that prevents optimistically biased evaluations due to overfitting. 54 Three groups of features, morphological, kinetic, and spatiotemporal, were used and combined to select a classifier. These groups of features are composed of features both original and already reported in literature, with the aim of trying a different approach. Specifically, morphological circularity, convexity, irregularity, and shape index were used to describe breast lesions in DCE-MRI in Refs. 20, 33, and 55 Shape index is a well known measure which was used in many applications, and in this work is first introduced as quantitative descriptor for the internal enhancement pattern. ABSN was originally proposed in Ref. 40 for surface inspection on 3D binary images and is adapted in this work for grayscale images to quantify lesion border irregularity. ABSN gives similar information to the gradient histogram proposed in Ref. 20 which, however, characterizes both margin and shape. To the authors' knowledge, peripherals uptake coefficients are first introduced in this work as quantitative descriptors for the rim enhancement sign. Similarly for kinetic features, the area under the contrast enhancement curve (AUCEC) and its initial part were used in kinetic analysis of breast lesion in Ref. 56 , whereas uptake and washout coefficients of the analytical function reported in Eq. (9) are originally proposed in this work. The enhancement kinetic featured were calculated in the whole lesion volume rather than in a lesion hot spot. The measure of these features for a hot spot at subjective evaluation has been demonstrated to have a high diagnostic value for mass lesion in reports with only ROI-based manual lesion analysis, so that the worst scenario approach was used. However, this generally resulted in a high sensitivity but a suboptimal specificity, not considering the entire pattern of lesion enhancement. Finally, all spatiotemporal features are first suggested in this work. The developed spatiotemporal features although were originally inspired by the internal enhancement BI-RADS descriptors, they actually widely extend them (higher complexity, quantitative, full use of all time frames,…), and they can not be closely related to the BI-RADS any more. The proposed spatiotemporal features are aimed to extract information from the change over time of the tumor contrast pattern for the purposes of a CADx system, they are not designed to be used as a separate diagnostic tool.
The entire CADx system from segmentation to discrimination is fully automatic, increasing the objectivity of breast MR image interpretation, since the interobserver variability in lesion outlining and discrimination is avoided. Recently, in literature, similar automatic systems, which combine different classes of features, have been proposed with varying performances. [32] [33] [34] [35] Notably, these studies were mainly focused on the development of spatiotemporal features. In particular, Woods et al. computed a four-dimensional cooccurrence matrix to calculate texture features in a pixelwise fashion, Zheng et al. used 2D discrete Fourier transformation (DFT) and Hu's moment invariants computed on a selected set of images, Lee et al. employed singular value decomposition and 3D moment descriptors, Agner et al. studied kinetic texture by gradient filters and co-occurrence Haralick's features. In the present work, we focus on the combination of three classes of features by genetic search and to the development of some new features for each class of feature. Considering the spatiotemporal features, we propose a different approach based on new dedicated maps, instead of using kinetic parametric maps as in Zheng et al., 33 Lee et al., 34 and Agner et al. 35 The performances obtained are comparable to those reported in these previous studies.
There are some limitations in this study. First, the dataset is composed of a limited number of lesions. This can produce an overfitting during training and limit the evaluation of performances. This problem was addressed by the use of limited number of features and a stratified tenfold crossvalidation. Second, the number of malignant lesions is larger than that of benign lesions, leading to a possible bias in the discrimination of malignancy. This effect was limited by presenting at training the same number of malignant and benign lesions. The benign minority class was filled in of copies of benign lesions belonging to the N À 1 folds used for training until to reach the same number of malignant lesions used for training. Nevertheless, the benign class is only partially described in the feature space because of the limited number of available lesions. A validation test is needed with larger number of cases. Third, this study analyzed only mass-like lesions. Detection, segmentation, and characterization of lesion presenting nonmass-like enhancement by automatic software is a different challenge due to different morphology and low diagnostic value of dynamics for these lesions, especially considering the relatively high probability of DCIS with continuous increase. 28, 31 In conclusion, we showed that automatic combinations of morphological, kinetic, and spatiotemporal features of masslike lesion at breast MRI allow for a better diagnostic performance of each individual group of features. For accurate diagnosis, an effective feature subset selection based on a genetic algorithm was applied with stratified cross-validation in order to select optimal subset of features. Our proposed CADx framework has a potential for improving diagnostic performance in breast DCE-MRI. A further analysis has to be carried to validated these conclusions on a larger dataset. 
